Objectives:

  1. Discuss the prevalence and potential risks with supplement and cannabis use by patients with cancer
  2. Identify common resources to screen supplements for potential treatment interactions
  3. identify commonly reported supplements and potential interactions with chemotherapy or targeted therapy
  4. Outline considerations for cannabidiol (CBD) or tetrahydrocannabinol (THC) use in patients with cancer
  5. Explain the oncology pharmacist approach to navigating supplement use in patients with cancer

Zoom Info:

Join from a PC, Mac, iPad, iPhone or Android device: Please click this URL to join. Passcode: Grand https://uwmadison.zoom.us/s/93795409378?pwd=SWRzR1R6cE1HN0dTM2lRbmQvV1NMdz09

Or One tap mobile: +13126266799,,93795409378# US (Chicago); +16469313860,,93795409378# US

Or join by phone: Dial(for higher quality, dial a number based on your current location). Webinar ID: 937 9540 9378

Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) or 162.255.36.11 (US East)

  • Webinar ID: 937 9540 9378
  • Passcode: 864581

 SIP: 93795409378@zoomcrc.com; Passcode: 864581

Session date: 
03/22/2023 - 8:00am to 9:00am CDT
Location: 
In-person and Virtually
750 Highland Avenue (HSLC)
HSLC 1306
Madison, WI 53705
United States
  • 1.00 AAPA Category 1 CME
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 ACPE Contact Hours - Pharmacist Technician
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Dr. Lindsey Jung
Dr. Elizabeth Dow-Hillgartner